[ Price : $8.95]
FDA publishes the FY 2025 Quarter 2 update to the CBER/CDER Data Standards Program Action Plan.[ Price : $8.95]
FDA grants Clarametyx Biosciences both fast track and qualified infectious disease product designations for its lead therapeutic c...[ Price : $8.95]
FDA warns Italys Mectronic Medicale about Quality System, Medical Device Reporting, and other violations in its illegal manufactur...[ Price : $8.95]
FDAs Oncology Center of Excellence announces a two-day virtual public workshop to advance the development of patient registries in...[ Price : $8.95]
Philips Respironics recalls (Class 1 device correction) its V30, A30, and A40 ventilators to update their use instructions due to ...[ Price : $8.95]
Anixa Biosciences assumes full sponsorship of a Cleveland Clinic IND for ian experimental breast cancer vaccine as it heads towar...[ Price : $8.95]
A new report from STAT describes drug review turmoil at FDA that led to FDA Oncology Center of Excellence director Richard Pazdur ...[ Price : $8.95]
HHS acting general counsel Sean Keveney is appointed FDAs new chief counsel.